News Column

ENANTA PHARMACEUTICALS INC FILES (8-K) Disclosing Change in Directors or Principal Officers

February 11, 2014

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officer.

Appointment of George Golumbeski to Board of Directors

On February 7, 2014, the Board of Directors of Enanta Pharmaceuticals, Inc. appointed George Golumbeski to serve as an independent director of the Company in the class of directors whose terms expire at Enanta's 2015 Annual Meeting of Stockholders and as a member of the Compensation and Nominating and Corporate Governance Committees of the Board of Directors.

Mr. Golumbeski will receive the standard compensation for non-employee directors of Enanta, including retainer fees for Board and committee service and stock options, and will have the benefit of the Company's standard form of indemnification agreement.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools